FACE TO FACE: Arun Prakash, Founder & CEO, Genetix Biotech Asia

In an exclusive rapid-fire interview on the sidelines of Global Bio India 2024 in New Delhi, Rahul Koul, Chief Editor, BioVoice News spoke to Arun Prakash, Founder & Chief Executive Officer, Genetix Biotech Asia. Mr Prakash shared his insights on his company’s key focus areas, industry’s growth drivers, government policies, India’s US$ 300 billion bioeconomy target and much more.

Key Questions

♦ How do you look at the growth of Indian biotechnology industry over the last few years?

♦ Genetix Biotech Asia caters to a wide range of clients in India including industry and academia. How has the company grown in the last few years?

♦ The government has recently unveiled the BIOE3 policy. How do you look at this policy and the broader US$ 300 billion bioeconomy by 2030?

♦ Your future outlook for the company and bioscience market in India?

About Arun Prakash:

With over 34 years of rich experience, Arun Prakash is a first-generation entrepreneur and has built his company from the scratch. He has created a unique best product mix with best quality and logistic support. In 2010, he created the ‘Genetix Brand’ and in 2011, diversified into core healthcare with medical devices with the formation of ‘365 Medical’ for distribution of products for Advance Wound Management, Critical Care and Ostomy. Under his leadership, Genetix became the first company in life sciences to start warehousing products and the only one to come up with the first catalogue in 1996. Genetix has Pan-India presence and distributes over 15,000 SKUs with a network of over 50 sub-dealers.

Click here now to watch the full interview for detailed insights.